Literature DB >> 29569088

Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives.

Zhipeng Zhang1, Di Shi1, Qiang Zhang1, Si Wang1, Kai Liu1, Qingtao Meng1, Xiaoping Chen2.   

Abstract

Prehypertension (defined by The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, JNC-7) is relevant to a higher cardiovascular risk than normotensives. Early intervention in this particular population is essential to avoid progression into hypertension (HTN). This study is to explore whether visceral adiposity index (VAI) can strongly predict the incidence of HTN in community-based prehypertensives. A prospective observational cohort study was conducted from September 2011 to June 2012 in urban communities of Chengdu, Sichuan Province, China. 780 subjects (male 320, female 460) were evaluated on anthropometrical indices, blood pressure, blood samples, brachial-ankle pulse wave velocity, of whom 360 prehypertensives (male 160, female 200) were recruited for a 5-year follow-up. Overall, 97 subjects (male 37, female 60) developed HTN. The risk for developing HTN in the future increases with increasing VAI levels. The OR of the upper quartile is 3.719 (95% CI 1.481-9.338, P = 0.005) after adjusting for confounders. The ROC results reveal that VAI is not considered superior to other indices on account of the significant overlapping confidence intervals. The area under the curves (AUC) of Model 5 (combination of VAI and WC) is significantly higher than BMI, WC and WHR (P < 0.05). The AUC of Model 4 (combination of VAI and BMI) is found to be significantly higher than BMI and WHR (P < 0.05), and is also higher than WC in all subject groups and in the male subgroup, but not in the female subgroup. VAI at baseline is an independent risk factor and early predictor of incident HTN in prehypertensives. The predictive value is not stronger than other traditional obesity indices (BMI, WC and WHR); however, it is superior to the latter by combining VAI and WC. Namely, VAI may help identify individuals at high risk of evolving into HTN in this particular population.

Entities:  

Keywords:  BaPWV; Prehypertension; Visceral adiposity index

Mesh:

Year:  2018        PMID: 29569088     DOI: 10.1007/s11739-018-1836-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  23 in total

Review 1.  Prehypertension--prevalence, health risks, and management strategies.

Authors:  Brent M Egan; Sean Stevens-Fabry
Journal:  Nat Rev Cardiol       Date:  2015-02-17       Impact factor: 32.419

Review 2.  Prehypertension: Defining the Transitional Phenotype.

Authors:  Camilo Fernandez; Gary E Sander; Thomas D Giles
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

3.  Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region.

Authors:  Hisatomi Arima; Yoshitaka Murakami; Tai Hing Lam; Hyeon Chang Kim; Hirotsugu Ueshima; Jean Woo; Il Suh; Xianghua Fang; Mark Woodward
Journal:  Hypertension       Date:  2012-04-30       Impact factor: 10.190

4.  Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.

Authors:  Marco C Amato; Carla Giordano; Massimo Galia; Angela Criscimanna; Salvatore Vitabile; Massimo Midiri; Aldo Galluzzo
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

5.  Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort.

Authors:  Tine Willum Hansen; Jan A Staessen; Haifeng Zhang; Christian Torp-Pedersen; Susanne Rasmussen; Lutgarde Thijs; Hans Ibsen; Jørgen Jeppesen
Journal:  Am J Hypertens       Date:  2007-05       Impact factor: 2.689

6.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

7.  Significantly increased visceral adiposity index in prehypertension.

Authors:  Yanan Ding; Dongfeng Gu; Yanxuan Zhang; Wenjie Han; Hengliang Liu; Qingshan Qu
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

8.  Prevalence and Correlates of Prehypertension and Hypertension among Adults in Northeastern China: A Cross-Sectional Study.

Authors:  Guang Yang; Yue Ma; Shibin Wang; Yingying Su; Wenwang Rao; Yingli Fu; Yaqin Yu; Changgui Kou
Journal:  Int J Environ Res Public Health       Date:  2015-12-25       Impact factor: 3.390

9.  Prehypertension and Hypertension among Schoolchildren in Brazzaville, Congo.

Authors:  Bertrand Fikahem Ellenga Mbolla; Annie Rachel Okoko; Jean Robert Mabiala Babela; Gaston Ekouya Bowassa; Thierry Raoul Gombet; Suzy-Gisèle Kimbally-Kaky; Benjamin Longo-Mbenza
Journal:  Int J Hypertens       Date:  2014-05-20       Impact factor: 2.420

10.  Prevalence of prehypertension and associated risk factors among Chinese adults from a large-scale multi-ethnic population survey.

Authors:  Tao Xu; Junting Liu; Guangjin Zhu; Junxiu Liu; Shaomei Han
Journal:  BMC Public Health       Date:  2016-08-11       Impact factor: 3.295

View more
  9 in total

1.  Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives.

Authors:  Teresa Vanessa Fiorentino
Journal:  Intern Emerg Med       Date:  2018-04-26       Impact factor: 3.397

2.  Visceral Adiposity Index is a predictor of incident colorectal cancer: a population-based longitudinal study.

Authors:  Takuro Okamura; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  BMJ Open Gastroenterol       Date:  2020-06

3.  A novel predicted model for hypertension based on a large cross-sectional study.

Authors:  Zhigang Ren; Benchen Rao; Siqi Xie; Ang Li; Lijun Wang; Guangying Cui; Tiantian Li; Hang Yan; Zujiang Yu; Suying Ding
Journal:  Sci Rep       Date:  2020-06-30       Impact factor: 4.379

4.  Association of Visceral Adiposity Index, Lipid Profile, and Serum Leptin with Glucose Intolerance Risks in Iraqi Obese Patients: A Cross-sectional Study.

Authors:  Wael Waleed Mustafa; Samer Shukur Moahammed; Wathiq Mohammed Al-Jewari; Hussein Saad Abdulrahman; Saad Abdulrahman Hussain
Journal:  J Pharm Bioallied Sci       Date:  2020-10-08

5.  Body mass index is superior to other body adiposity indexes in predicting incident hypertension in a highly admixed sample after 10-year follow-up: The Baependi Heart Study.

Authors:  Camila Maciel de Oliveira; Francielle França da Rosa; Rafael de Oliveira Alvim; Carlos Alberto Mourão Junior; Mercedes Bacells; Chunyu Liu; Jessica Pavani; Robson Capasso; Fernando Augusto Lavezzo Dias; José Eduardo Krieger; Alexandre Costa Pereira
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-05-11       Impact factor: 2.885

6.  Higher visceral adiposity index is associated with increased likelihood of abdominal aortic calcification.

Authors:  Zheng Qin; Luojia Jiang; Jiantong Sun; Jiwen Geng; Shanshan Chen; Qinbo Yang; Baihai Su; Ruoxi Liao
Journal:  Clinics (Sao Paulo)       Date:  2022-09-24       Impact factor: 2.898

7.  The relationship between the visceral adiposity index and carotid atherosclerosis in different genders and age groups.

Authors:  Jing Cao; Shengpeng Liu; Hebin Xie; Yu Zhang; Yalin Zeng
Journal:  Saudi Med J       Date:  2022-02       Impact factor: 1.422

8.  The Visceral Adipose Index in Relation to Incidence of Hypertension in Chinese Adults: China Health and Nutrition Survey (CHNS).

Authors:  Yong Xue; Qun Shen; Chang Li; Zijian Dai; Tingchao He
Journal:  Nutrients       Date:  2020-03-18       Impact factor: 5.717

9.  Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran.

Authors:  Behrooz Hamzeh; Yahya Pasdar; Narmin Mirzaei; Roya Safari Faramani; Farid Najafi; Ebrahim Shakiba; Mitra Darbandi
Journal:  Lipids Health Dis       Date:  2021-08-01       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.